CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 4 Planned sale Director sold 3,150 shares at an average $316.00 ($995,405)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 112 shares at an average $399.97 ($44,797)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 748 shares at an average $400.02 ($299,214)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 341 shares at an average $400.05 ($136,416)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,419 shares at an average $409.77 ($1,400,994)
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 302 shares at an average $400.01 ($120,804)
- 4 Planned sale CEO AND PRESIDENT sold 3,801 shares at an average $411.80 ($1,565,239)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 795 shares at an average $394.97 ($313,998)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 94 · 1,862 filings